Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$0.6 - $1.53 $87,093 - $222,087
-145,155 Reduced 0.86%
16,764,480 $10.1 Million
Q2 2023

Aug 14, 2023

SELL
$1.05 - $1.63 $57,376 - $89,069
-54,644 Reduced 0.32%
16,909,635 $19.1 Million
Q1 2023

May 03, 2023

SELL
$1.2 - $2.73 $350,258 - $796,837
-291,882 Reduced 1.69%
16,964,279 $22.9 Million
Q4 2022

Feb 13, 2023

SELL
$1.71 - $3.61 $32,814 - $69,275
-19,190 Reduced 0.11%
17,256,161 $32.1 Million
Q3 2022

Nov 14, 2022

SELL
$1.9 - $8.63 $459,195 - $2.09 Million
-241,682 Reduced 1.38%
17,275,351 $42.7 Million
Q2 2022

Aug 04, 2022

SELL
$2.13 - $9.01 $2.76 Million - $11.7 Million
-1,294,895 Reduced 6.88%
17,517,033 $42.6 Million
Q1 2022

May 06, 2022

SELL
$6.28 - $15.59 $1.17 Million - $2.91 Million
-186,525 Reduced 0.98%
18,811,928 $151 Million
Q4 2021

Feb 08, 2022

BUY
$14.7 - $28.67 $27.5 Million - $53.7 Million
1,873,864 Added 10.94%
18,998,453 $293 Million
Q3 2021

Nov 09, 2021

BUY
$24.31 - $33.6 $55 Million - $76 Million
2,261,248 Added 15.21%
17,124,589 $490 Million
Q2 2021

Aug 09, 2021

BUY
$26.09 - $40.4 $31.4 Million - $48.6 Million
1,202,186 Added 8.8%
14,863,341 $499 Million
Q1 2021

May 03, 2021

BUY
$33.06 - $56.93 $79.5 Million - $137 Million
2,405,541 Added 21.37%
13,661,155 $522 Million
Q4 2020

Feb 11, 2021

SELL
$39.09 - $57.4 $630,521 - $925,862
-16,130 Reduced 0.14%
11,255,614 $471 Million
Q3 2020

Nov 02, 2020

SELL
$28.43 - $44.67 $27 Million - $42.4 Million
-949,415 Reduced 7.77%
11,271,744 $494 Million
Q2 2020

Aug 07, 2020

SELL
$11.71 - $30.29 $10.2 Million - $26.4 Million
-870,966 Reduced 6.65%
12,221,159 $356 Million
Q1 2020

Apr 30, 2020

BUY
$7.64 - $27.5 $23.2 Million - $83.5 Million
3,035,085 Added 30.18%
13,092,125 $179 Million
Q4 2019

Feb 06, 2020

BUY
$15.02 - $20.57 $41.4 Million - $56.7 Million
2,757,337 Added 37.77%
10,057,040 $162 Million
Q3 2019

Oct 29, 2019

BUY
$18.85 - $27.5 $37.1 Million - $54.1 Million
1,966,915 Added 36.88%
7,299,703 $141 Million
Q2 2019

Jul 29, 2019

BUY
$17.37 - $26.27 $73.3 Million - $111 Million
4,217,463 Added 378.14%
5,332,788 $125 Million
Q1 2019

Apr 30, 2019

BUY
$10.65 - $25.75 $11.8 Million - $28.5 Million
1,107,677 Added 14483.22%
1,115,325 $26.1 Million
Q4 2018

Feb 08, 2019

SELL
$9.26 - $16.38 $1,518 - $2,686
-164 Reduced 2.1%
7,648 $85,000
Q3 2018

Oct 15, 2018

BUY
$7.54 - $18.31 $58,902 - $143,037
7,812 New
7,812 $136,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Nikko Asset Management Americas, Inc. Portfolio

Follow Nikko Asset Management Americas, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.